Skip to content
ISSN: 1792-7110
HAEMA
The Journal of the Hellenic Society of HAEMATOLOGY
  • HOME
  • ABOUT
    • JOURNAL INFORMATION
    • EDITORIAL BOARD
  • CURRENT ISSUE
  • AUTHORS
  • ARCHIVE
    • VOLUME 14 (2023)
      • HAEMA 2023 (Suppl 1)
    • VOLUME 13 (2022)
      • HAEMA 2022 (1-2)
      • HAEMA 2022 (Suppl 1)
    • VOLUME 12 (2021)
      • HAEMA 2021 (1)
      • HAEMA 2021 (Suppl 1)
    • VOLUME 11 (2020)
      • HAEMA 2020 (Suppl 1)
    • VOLUME 10 (2019)
      • HAEMA 2019 (1)
      • HAEMA 2019 (2)
      • HAEMA 2019 (Suppl 1)
    • VOLUME 9 (2018)
      • HAEMA 2018 (Suppl 1)
    • VOLUME 8 (2017)
      • HAEMA 2017 (1)
      • HAEMA 2017 (2)
      • HAEMA 2017 (4)
    • VOLUME 7 (2016)
      • HAEMA 2016 (1)
      • HAEMA 2016 (2)
      • HAEMA 2016 (3)
      • HAEMA 2016 (4)
    • VOLUME 6 (2015)
      • HAEMA 2015 (4)
    • VOLUME 5 (2014)
      • HAEMA 2014 (1)
      • HAEMA 2014 (4)
    • VOLUME 4 (2013)
      • HAEMA 2013 (1)
      • HAEMA 2013 (2)
      • HAEMA 2013 (3)
      • HAEMA 2013 (4)
    • VOLUME 3 (2012)
      • HAEMA 2012 (1)
      • HAEMA 2012 (2)
      • HAEMA 2012 (3)
      • HAEMA 2012 (4)
    • VOLUME 2 (2011)
      • HAEMA 2011 (2)
      • HAEMA 2011 (3)
      • HAEMA 2011 (4)
    • VOLUME 1 (2010)
      • HAEMA 2010 (1)
      • HAEMA 2010 (2)
      • HAEMA 2010 (4)
  • SUBMIT YOUR MANUSCRIPT
  • CONTACT US

34rd Congress of the Hellenic Society of Haematology

Posted on November 9, 2023November 30, 2023 by admin

Haema 2023; 14(Suppl 1)

CONGRESS PROCEEDINGS

Full PDF (in Greek) |

Posted in Uncategorized
Post navigation
33rd Congress of the Hellenic Society of Haematology →

SEARCH

CURRENT ISSUE

Prognostic Significance of IDH1 and IDH2 Mutations in Greek Patients with Newly Diagnosed AML

The Role of Venetoclax in the Treatment of Acute Myeloid Leukemia

Very Late Relapses in Hodgkin Lymphoma: A Critical Comparison of Major Published Studies

Differential Diagnosis of Thrombotic Microangiopathies: From Bench to Bedside

Comment on: Bitsani et al “Prognostic Significance of IDH1 and IDH2 Mutations in Newly Diagnosed AML Patients in Greece”

A hot dark skeleton

  • About Us

    HAEMA is the official journal of the Hellenic Society of Hematology. HAEMA was founded in March 1998, since when it has been published regularly and has undergone several modifications,in both the language (Greek-English) and the content of the journal.
    The new edition of HAEMA is an English language, independent, open-access, peer reviewed journal, published quarterly.

  • FIND ARTICLE BY KEYWORD

    5 years (1) Acute lymphoblastic leukemia (1) Acute myeloid leukemia (1) ALL (1) AML (1) Anemia (1) Anti-GDF11 drugs (1) BCR-JAK2 (1) Biochemical biomarkers (1) Blinatumomab (1) CAR-T cells (1) CD71 (1) Chemotherapy (1) Clinical trials (1) Complement inhibitors (1) Diagnosis (1) DLBCL (1) HELLP syndrome (1) Hematological (1) Hemolytic uremic syndrome (1) Hodgkin lymphoma (1) IDH1/IDH2 mutations (1) Inotuzumab ozogamicin (1) Iron overload (1) JAK2 (1) Mechanism of action (1) Mixed cellularity (1) Multiple myeloma (1) PET-CT (1) Ph-like ALL (1) Philadelphia-chromosome positive ALL (1) Prognosis (1) Radiotherapy (1) Relapse (1) Ruxolitinib (1) sTfR (1) Thrombotic microangiopathy (1) Thrombotic thrombocytopenic purpura (1) Transfusion related reactions (1) Transplant-associated thrombotic microangiopathy (1) Treatment (1) TRRC1 (1) Tyrosine-kinase inhibitors (1) Venetoclax (1) very late (1)
Theme by Out the Box